Navigation Links
BioMed Realty Trust Reports First Quarter 2008 Financial Results
Date:4/30/2008

124

We present funds from operations, or FFO, available to common shares and partnership and LTIP units because we consider it an important supplemental measure of our operating performance and believe it is frequently used by securities analysts, investors and other interested parties in the evaluation of REITs, many of which present FFO when reporting their results. FFO is intended to exclude GAAP historical cost depreciation and amortization of real estate and related assets, which assumes that the value of real estate assets diminishes ratably over time. Historically, however, real estate values have risen or fallen with market conditions. Because FFO excludes depreciation and amortization unique to real estate, gains and losses from property dispositions and extraordinary items, it provides a performance measure that, when compared year over year, reflects the impact to operations from trends in occupancy rates, rental rates, operating costs, development activities and interest costs, providing perspective not immediately apparent from net income. We compute FFO in accordance with standards established by the Board of Governors of the National Association of Real Estate Investment Trusts, or NAREIT, in its March 1995 White Paper (as amended in November 1999 and April 2002). As defined by NAREIT, FFO represents net income (computed in accordance with GAAP), excluding gains (or losses) from sales of property, plus real estate related depreciation and amortization (excluding amortization of loan origination costs) and after adjustments for unconsolidated partnerships and joint ventures. Our computation may differ from the methodology for calculating FFO utilized by other equity REITs and, accordingly, may not be comparable to such other REITs. Further, FFO does not represent amounts available for management's discretionary use because of needed capital replacement or expansion, debt service obligations, or other commitments and uncertainties. FFO should no
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. BioMed Realty Trust to Report 2008 First Quarter Results
2. The BBVA Foundation awards its 2007 Biomedicine Chairs
3. HHS Names First Director of the Biomedical Advanced Research Development Authority
4. BioMed Realty Trust Announces 90,000 Square Foot Lease at Pacific Research Center
5. DeBakey Awards to Recognize Excellence in Biomedical Research Journalism
6. LA BioMed to honor 3 of its legendary
7. Response Biomedical Corporation Reports 2007 Financial Results
8. Response Biomedical Corporation Moves to New Facility
9. Response Biomedical Corp. - Year End 2007 Earnings Webcast and Conference Call - March 31, 2008
10. LA BioMed researcher says unexpected increase in cancer risk found
11. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The federal court overseeing thousands of vaginal mesh ... District of West Virginia has upheld a $2 million verdict ... trial. In an Order dated January 21st, the Court denied ... C.R. Bard had not proven a miscarriage of justice. (Cisson ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
(Date:1/22/2015)... 22, 2015 Four years since the release of ... coincided with the marriage of Avasa & Matthew Love – the ... is scheduled for release through White Swan Records on February 24, ... is a sacred path available to all of us to walk ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX -,News), an ... to develop novel formulations of drugs, is ... Indaflex(TM), its topical NSAID,(Non-Steroidal Anti-Inflammatory Drug) formulation, ... ("Cypress,) (NASDAQ: CYPB )., In ...
... May 12 portionpals(R), an innovative,weight-loss tool is proud ... mark,this past Saturday, May 10th, in less than its ... alternative among consumers,looking for a healthy way to lose ... share in a multi-billion dollar industry with no national,distribution ...
... N.J., May 12 Medarex, Inc.,(Nasdaq: MEDX ) announced ... Including a gain of $151.8 million, or $1.19 per ... stock in February 2008, Medarex,s,net income for the quarter ended ... compared to a net income of $110.3 million, or $0.88,per ...
... MedCath Corporation,(Nasdaq: MDTH ), a health care ... the diagnosis and treatment of cardiovascular,disease, today announced ... Interim Chief Financial Officer, has been named,Senior Vice-President, ... new role, Art will continue to oversee and ...
... The American,Veterinary Medical Association (AVMA) has revised its ... veterinarians with additional guidance,for managing pain associated with ... 2008, does not dictate that practitioners use any,particular ... provides some,basic recommendations for consideration by practitioners when ...
... Authority Over Tobacco, WASHINGTON, May 9 ... today announces their,support of H.R. 1108, "The Family ... FDA regulatory authority over tobacco products., "We ... year.,H.R. 1108 has broad bi-partisan support and could ...
Cached Medicine News:Health News:AlphaRx's Indaflex(TM) Continues its Clinical Development 2Health News:Diet Industry Newcomer Hits the 1 Million Unit Mark 2Health News:Medarex Announces 2008 First Quarter Financial Results 2Health News:Medarex Announces 2008 First Quarter Financial Results 3Health News:Medarex Announces 2008 First Quarter Financial Results 4Health News:Medarex Announces 2008 First Quarter Financial Results 5Health News:Medarex Announces 2008 First Quarter Financial Results 6Health News:Medarex Announces 2008 First Quarter Financial Results 7Health News:Medarex Announces 2008 First Quarter Financial Results 8Health News:MedCath Names Parker to New Finance Post 2Health News:Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain 2
(Date:1/23/2015)... Jan. 23, 2015  Now available for sale, The Armor1 ... that prevents ankle sprains by cushioning the ankle from ... securely around the outside of any shoe type and ... while still offering protection against sprains. With customers in ...
(Date:1/23/2015)... N.J. , Jan. 23, 2015  CytoSorbents Corporation ... commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce ... announced the receipt of $385,642, net of transaction ... of the Technology Business Tax Certificate Transfer Program ...
(Date:1/22/2015)... privately held medical device company, announced today that it ... Corporation (Tokyo Stock Exchange TYO: 8001) to sell its ... in Japan . ViewRay,s technology, the ... MRI-guided radiation therapy system that images and treats cancer ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... the only approved radiolucent stand-alone implant that ... the proven reliability of the BAK threaded ... is constructed of radiolucent, carbon-fiber reinforced PEEK-OPTIMA ... visualization, providing a new level of confidence ...
... (bDNA) delivers unmatched precision and reproducibility, so you ... viral load values they can trust.,you detect significant ... critical decision points - without the variability seen ... to choose VERSANT HIV bDNA, consider this: it's ...
... The AMPLICOR HIV-1 MONITOR Test, v1.5, an FDA-approved ... load testing, has been used in the regulatory ... in eight out of 10 clinical laboratories worldwide. ... v1.5 is an in vitro nucleic acid amplification ...
... Recombigen HIV is a single use rapid test, ... plasma, serum and whole blood (venipuncture). Uni-Gold Recombigen ... care settings as an aid in diagnosis of ... use in appropriate multi-test algorithms designed for the ...
Medicine Products: